As of Aug 16
| +0.20 / +0.32%|
The 21 analysts offering 12-month price forecasts for Merck have a median target of 70.00, with a high estimate of 75.00 and a low estimate of 52.00. The median estimate represents a +11.64% increase from the last price of 62.70.
The current consensus among 23 polled investment analysts is to Buy stock in Merck. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.